Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.

Refaie MMM, Rifaai RA, Fawzy MA, Shehata S.

Open source

DOI
10.1007/s12012-022-09768-0
Published
2022-10-15
Container
Cardiovasc Toxicol
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12012-022-09768-0,
  title = {Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.},
  author = {Refaie MMM and  Rifaai RA and  Fawzy MA and  Shehata S.},
  year = {2022},
  journal = {Cardiovasc Toxicol},
  doi = {10.1007/s12012-022-09768-0},
  url = {https://doi.org/10.1007/s12012-022-09768-0}
}

RIS

TY  - JOUR
TI  - Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.
AU  - Refaie MMM
AU  -  Rifaai RA
AU  -  Fawzy MA
AU  -  Shehata S.
PY  - 2022
JO  - Cardiovasc Toxicol
DO  - 10.1007/s12012-022-09768-0
UR  - https://doi.org/10.1007/s12012-022-09768-0
ER  - 

APA

MMM, R., RA, R., MA, F., & S., S. (2022). Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.. Cardiovasc Toxicol. https://doi.org/10.1007/s12012-022-09768-0

Source records